Please login to the form below

Not currently logged in
Email:
Password:

CHMP recommends Erbitux

Merck Serono has announced that the Committee for Medicinal Products for Human Use has given a positive recommendation for an application to extend the uses of its cancer drug, Erbitux
Merck Serono has announced that the Committee for Medicinal Products for Human Use (CHMP) has given a positive recommendation for an application to extend the uses of its cancer drug, Erbitux.

The drug has already been approved for the treatment of colorectal cancer (CRC) in Europe and was licensed for use on the market in June 2004. Merck and Serono hope to extend the use of Erbitux to include the treatment of metastatic colorectal cancer (mCRC) with KRAS wild-type tumours, and is to be used in combination with chemotherapy.

The company, a division of global pharmaceutical manufacturer and developer, Merck, said that the scientific committee at the European Medicines Agency (EMEA) also gave its backing for the application.

Dr Wolfgang Wein, executive vice-president of oncology at Merck, said: "The positive opinion from the CHMP is an important step forward in the management of CRC and a step closer to tailored therapy for cancer patients."

30th May 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics